Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation: a brief commentary

Elise Wouters,* Maurice Steenhuis,* Hubert Schrezenmeier, Pierre Tiberghien, Heli Harvala, Hendrik B. Feys & Ellen van der Schoot Transfusion Research Center, Belgian Red Cross-Flanders, Ghent, Belgium Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, Netherlands Department of Transfusion Medicine, Ulm University, Ulm, Germany Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-W€urttemberg – Hessen and University Hospital Ulm, Ulm, Germany Etablissement Franc ais du Sang, La Plaine St-Denis, France UMR1098 RIGHT, INSERM, Etablissement Franc ais du Sang, Universit e de Franche-Comt e, Besanc on, France Microbiology Services, NHS Blood and Transplant, London, UK

[1]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. , 2021, The Cochrane database of systematic reviews.

[2]  T. Bhatnagar,et al.  Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) , 2020, BMJ.

[3]  E. Seifried,et al.  Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing , 2020, The Journal of infectious diseases.

[4]  G. Rodger,et al.  Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison , 2020, The Lancet Infectious Diseases.

[5]  P. Bieniasz,et al.  Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients , 2020, Journal of Clinical Microbiology.

[6]  M. Koller,et al.  A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization , 2020, Infection.

[7]  R. Olsen,et al.  Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality , 2020, The American Journal of Pathology.

[8]  E. Bloch.  Convalescent plasma to treat COVID-19 , 2020, Blood.

[9]  H. Ullum,et al.  Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories , 2020, medRxiv.

[10]  E. Wood,et al.  Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. , 2020, The Cochrane database of systematic reviews.

[11]  M. Koopmans,et al.  An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment , 2020, Nature Communications.

[12]  Rachel J. Johnson,et al.  Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  G. Torriani,et al.  Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2 , 2020, Journal of Clinical Microbiology.

[14]  E. Theel,et al.  Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2 , 2020, Journal of Clinical Microbiology.

[15]  A. Casadevall,et al.  A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. , 2020, JAMA.

[16]  P. Simmonds,et al.  Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels , 2020, medRxiv.

[17]  Gagan Mathur,et al.  Antibody Testing For Covid-19 , 2020, American journal of clinical pathology.

[18]  Jordan J. Clark,et al.  Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[20]  A. Malik,et al.  Protein transport across the lung epithelial barrier. , 2003, American journal of physiology. Lung cellular and molecular physiology.